The Influence of Cessation of Pomegranate Juice Intake on Inflammation and Oxidative Stress Markers and Glucose Control in Diabetic and Non Diabetic Chronic Hemodialysis Patients
|ClinicalTrials.gov Identifier: NCT01033435|
Recruitment Status : Completed
First Posted : December 16, 2009
Last Update Posted : August 17, 2011
The current study will investigate chronic hemodialysis patients who were treated in our unit with pomegranate juice intake for 1 year - compared to a control group.
Markers will be taken 3 months after cessation of pomegranate juice intake, for inflammation and oxidative stress and Hb A1c.
|Condition or disease||Intervention/treatment|
|Inflammation Oxidative Stress||Other: No intervention|
|Study Type :||Observational|
|Actual Enrollment :||49 participants|
|Observational Model:||Case Control|
|Study Start Date :||December 2009|
|Actual Study Completion Date :||August 2011|
|chronic Hemodialysis patients, treated in our unit.||Other: No intervention|
chronic Hemodialysis patients , No intervention
chronic Hemodialysis patients, treated in our unit.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01033435
|Western Galilee Hospital|
|Nahariya, Western Galilee, Israel, 25100|